These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8110025)

  • 21. Effects in the mouse and rat of prenatal exposure to arsenic.
    Hood RD; Thacker GT; Patterson BL
    Environ Health Perspect; 1977 Aug; 19():219-22. PubMed ID: 908302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the developmental effects on mice after prenatal, or pre- and postnatal exposure to 2,3-dimercaptopropane-1-sulfonic acid (DMPS).
    Domingo JL; Ortega A; Bosque MA; Corbella J
    Life Sci; 1990; 46(18):1287-92. PubMed ID: 2345481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride.
    Gonzalez-Ramirez D; Zuniga-Charles M; Narro-Juarez A; Molina-Recio Y; Hurlbut KM; Dart RC; Aposhian HV
    J Pharmacol Exp Ther; 1998 Oct; 287(1):8-12. PubMed ID: 9765315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of various dithiol compounds in acute As2O3 poisoning in mice.
    Kreppel H; Reichl FX; Szinicz L; Fichtl B; Forth W
    Arch Toxicol; 1990; 64(5):387-92. PubMed ID: 2169719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antagonism of acute copper(II)-induced renal lesions by sodium 2,3-dimercaptopropanesulfonate.
    Mitchell WM; Basinger MA; Jones MM
    Johns Hopkins Med J; 1982 Dec; 151(6):283-5. PubMed ID: 7176288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dithiol chelating agents on [3H]MK-801 and [3H]glutamate binding to synaptic plasma membranes.
    Nogueira CW; Rocha JB; Souza DO
    Neurochem Res; 2001 Dec; 26(12):1305-10. PubMed ID: 11885782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention by tiopronin (2-mercaptopropionyl glycine) of methylmercuric chloride-induced teratogenic and fetotoxic effects in mice.
    Fujimoto T; Fuyuta M; Kiyofuji E; Hirata S
    Teratology; 1979 Oct; 20(2):297-301. PubMed ID: 524302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chelators on mercury, iron, and lead neurotoxicity in cortical culture.
    Rush T; Hjelmhaug J; Lobner D
    Neurotoxicology; 2009 Jan; 30(1):47-51. PubMed ID: 19027035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo evaluation of teratogenesis and cytogenetic changes following methylmercuric chloride treatment.
    Curle DC; Ray M; Persaud TV
    Anat Rec; 1987 Nov; 219(3):286-95. PubMed ID: 3425947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA.
    Zalups RK; Bridges CC
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):10-7. PubMed ID: 19063911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inorganic mercury exposure, mercury-copper interaction, and DMPS treatment in rats.
    Blanusa M; Prester L; Radić S; Kargacin B
    Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):305-7. PubMed ID: 7843122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the effect of BAL (2,3-dimercaptopropanol) on arsenite-induced teratogenesis in mice.
    Hood RD; Vedel-Macrander GC
    Toxicol Appl Pharmacol; 1984 Mar; 73(1):1-7. PubMed ID: 6710506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of oral treatment with Bal, DMPS or DMSA arsenic in organs of mice injected with arsenic trioxide.
    Schäfer B; Kreppel H; Reichl FX; Fichtl B; Forth W
    Arch Toxicol Suppl; 1991; 14():228-30. PubMed ID: 1666826
    [No Abstract]   [Full Text] [Related]  

  • 35. Subchronic treatment with sodium 2,3-dimercaptopropane-1-sulfonate in methylmercury poisoning.
    Schäfer SG; Storp M; Richter E
    Bull Environ Contam Toxicol; 1982 Oct; 29(4):416-21. PubMed ID: 7171852
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of a mechanism by which the methylmercury antidotes N-acetylcysteine and dimercaptopropanesulfonate enhance urinary metal excretion: transport by the renal organic anion transporter-1.
    Koh AS; Simmons-Willis TA; Pritchard JB; Grassl SM; Ballatori N
    Mol Pharmacol; 2002 Oct; 62(4):921-6. PubMed ID: 12237339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate.
    Cherian MG; Miles EF; Clarkson TW; Cox C
    J Pharmacol Exp Ther; 1988 May; 245(2):479-84. PubMed ID: 3367303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. I. Evidence for carrier mediated transport.
    Wildenauer DB; Reuther H; Weger N
    Chem Biol Interact; 1982 Nov; 42(2):165-77. PubMed ID: 7151227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
    Nogueira CW; Soares FA; Nascimento PC; Muller D; Rocha JB
    Toxicology; 2003 Mar; 184(2-3):85-95. PubMed ID: 12499112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of 2,3-dimercaptopropane-1-sulfonate in treatment of lead poisoning in children.
    Chisolm JJ; Thomas DJ
    J Pharmacol Exp Ther; 1985 Dec; 235(3):665-9. PubMed ID: 4078728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.